外周血中CEA和CA19-9的表达水平在进展期胃癌中的预后价值

doi:10.11904/j.issn.1002-3070.2017.04.010

实用肿瘤学杂志 ›› 2017, Vol. 31 ›› Issue (4): 342-347.doi: 10.11904/j.issn.1002-3070.2017.04.010

外周血中CEA和CA19-9的表达水平在进展期胃癌中的预后价值

张锡¹,陈力²,薛英威¹

1.哈尔滨医科大学附属肿瘤医院外科(哈尔滨 150081);
2.哈尔滨医科大学附属肿瘤医院胃肠外科

收稿日期:2017-04-12 出版日期:2017-08-20 发布日期:2017-08-23
通讯作者: 薛英威,E-mail:xueyingwei1964@163.com
作者简介:张锡,男,(1987-),硕士,住院医师,从事胃肠道肿瘤临床与基础的研究

Prognostic value of CEA and CA19-9 expression in peripheral blood of patients with advanced gastric cancer

ZHANG Xi¹,CHEN Li²,XUE Yingwei¹

1.Department of Surgery,Harbin Medical University Cancer Hospital,Harbin 150081,China;
2.Department of Gastrointestinal Surgery,Harbin Medical University Cancer Hospital

Received:2017-04-12 Online:2017-08-20 Published:2017-08-23

摘要/Abstract

摘要： 目的探讨外周血中CEA和CA19-9的表达水平在进展期胃癌中的预后价值及进展期胃癌患者预后的影响因素。方法选取2010年1月—2010年12月于哈尔滨医科大学附属肿瘤医院胃肠外科行R0根治术的进展期胃癌患者255例,根据CEA和CA19-9的表达水平分为A组(CEA＜2.19ng/mL且CA19-9＜10.78U/mL)、B组(CEA≥2.19ng/mL或CA19-9≥10.78U/mL)和C组(CEA≥2.19ng/mL且CA19-9≥10.78U/mL),比较三组进展期胃癌患者的临床病理资料和生存情况,并分析进展期胃癌患者预后的影响因素。结果三组进展期胃癌患者间临床N分期、临床TNM分期和病理TNM分期的差异均具有统计学意义(P＜0.05),三组进展期胃癌患者术后中位生存时间差异无统计学意义(P＞0.05);术后1年、3年、5年生存率差异无统计学意义(P＞0.05),但A组1年、3年、5年生存率高于B组和C组。影响胃癌预后的因素包括肿瘤分化程度、病理T分期、病理TNM分期、清扫淋巴结总数、清扫淋巴结阳性数、淋巴结转移情况。结论 CEA和CA19-9联合检测对进展期胃癌患者评估预后有一定的参考价值。

关键词: 进展期胃癌, CEA, CA19-9, 总生存时间

Abstract: Objective The aims of this study were to investigate the prognostic value of CEA and CA19-9 expression in advanced gastric cancer and the prognostic factors of advanced gastric cancer.Methods A total of 255 patients with advanced gastric cancer who underwent radical R0 radical surgery were enrolled in the Department of Gastrointestinal Surgery,Harbin Medical University Cancer Hospital from January 2010 to December 2010,and were divided into group A(CEA＜2.19ng/mL and CA19-9＜10.78U/mL),group B(CEA≥2.19ng/mL or CA19-9≥10.78U/mL)and group C(CEA≥2.19ng/mL and CA19-9≥10.78U/mL).These groups were analyzed the differences in gastric cancer patients with clinical pathology and survival,and prognostic factors of patients with advanced gastric cancer factors.Results There were statistically significant differences in clinical N staging,clinical TNM staging and pathological TNM staging in three groups of patients with advanced gastric cancer(P＜0.05).There was no significant difference in the median survival time in three groups of patients with advanced gastric cancer(P＞0.05).The 1-year,3-year and 5-year survival rates of group A were higher than those of group B and group C(P＞0.05).The factors affecting the prognosis of gastric cancer included the degree of tumor differentiation,pathological T staging,pathological TNM staging,the total number of lymph nodes,the number of positive lymph nodes and lymph node metastasis.Conclusion Combined detection of CEA and CA19-9 expression indicates a certain reference value for prognosis of gastric cancer.

Key words: Advanced gastric cancer, CEA, CA19-9, Overall survival time

中图分类号:

R735.2

张锡,陈力,薛英威. 外周血中CEA和CA19-9的表达水平在进展期胃癌中的预后价值[J]. 实用肿瘤学杂志, 2017, 31(4): 342-347.

ZHANG Xi ,CHEN Li ,XUE Yingwei. Prognostic value of CEA and CA19-9 expression in peripheral blood of patients with advanced gastric cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(4): 342-347.

参考文献

1 Rebecca LS,Kimberly DM,Ahmedin J,et al.Cancer Statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
2 陈力,张玉新,左艳娇,等.SOX和XELOX在进展期胃癌新辅助化疗中的临床疗效比较[J].实用肿瘤学杂志,2017,31(1):23-30.
3 丁洪基.肿瘤干细胞与肿瘤淋巴管生成及转移的研究进展[J].诊断病理学杂志,2017,24(3):227-231.
4 李凯,王振宁.胃癌术后肿瘤标记物检测及其研究进展[J].中国实用外科杂志,2015,35(10):1137-1140.
5 吴伟晴,廖淑萍,林小兰,等.血清肿瘤标志物在五种消化系统肿瘤诊断中的价值[J].现代消化及介入诊疗,2016,21(4):550-554.
6 Rahman R,Asombang AW,Ibdah JA.Characteristics of gastric cancer in Asia[J].World J Gastroentero,2014,20(16):4483-4490.
7 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
8 Duffy MJ,Lamerz R,Haglund C,et al.Tumor markers in colorectal cancer,gastric cancer and gastrointestinal stromal cancers:European group on tumor markers 2014 guidelines update[J].J Int Cancer,2014,134(11):2513-2522.
9 Jagric T,Potrc S,Mis K,et al.CA19-9 serum levels predict micrometastases in patients with gastric cancer[J].Radiol Oncol,2016,50(2):204-211.
10 徐巧玲,尤徐阳,吴娜静,等.临床病理学分析结合CEA、CA19-9与CA125检测对诊断胃癌术后腹膜转移的意义[J].标记免疫分析与临床,2016,121(11):1321-1326.
11 Yu J,Zhang S,Zhao B.Differences and correlation of serum CEA,CA19-9 and CA72-4 in gastric cancer[J].Mol Clin Oncol,2016,4(3):441-449.
12 Liu X,Qiu H,Liu J,et al.Combined preoperative concentrations of CEA,CA 19-9,and 72-4 for predicting outcomes in patients with gastric cancer after curative resection[J].Oncotarget,2016,7(23):35446-35453.
13 贾笑强,李永慧,杨晓霞,等.CEA、CA19-9 与CA72-4 用于诊断老年胃癌的临床价值研究[J].现代生物医学进展,2015,15(33):6469-6471.

[1]	张宝综述, 郑志超校审. 进展期胃癌淋巴结清扫研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 78-81.
[2]	陈力, 张玉新, 左艳娇, 马菲, 宋洪江, 薛英威. SOX和XELOX在进展期胃癌新辅助化疗中的临床疗效比较[J]. 实用肿瘤学杂志, 2017, 31(1): 23-30.
[3]	展超, 金宇, 张玉宝. 早中期胰腺癌患者血清特异性糖链与CA19-9、CEA检测比较的研究[J]. 实用肿瘤学杂志, 2015, 29(1): 7-11.
[4]	方东, 王志红. 中性粒细胞/淋巴细胞比值在大肠癌癌变进展中的指示价值[J]. 实用肿瘤学杂志, 2015, 29(1): 44-48.
[5]	徐京京, 杨明, 赵娟, 周艳华, 张艳桥. 胰腺癌切除术后预后相关因素的临床分析[J]. 实用肿瘤学杂志, 2012, 26(6): 543-547.
[6]	许亚晔, 陈学发, 李秀娟, 周振寿. 螺旋CT扫描对进展期胃癌浸润深度的研究[J]. 实用肿瘤学杂志, 2012, 26(2): 146-149.
[7]	徐兰, 李晓霞, 郭玉杰, 亢澜涛. 荧光定量PCR检测大肠癌患者CEA mRNA表达的研究[J]. 实用肿瘤学杂志, 2010, 24(2): 123-126.
[8]	林昭明, 李伟. 不同镇痛模式对行宫颈癌根治术病人细胞免疫功能的影响[J]. 实用肿瘤学杂志, 2009, 23(5): 473-475.
[9]	邱岩;罗娅红;于韬;李森. 应用低场MRI平扫评价进展期胃癌的胃壁及胃周浸润[J]. 实用肿瘤学杂志, 2008, 22(01): 32-34.
[10]	王升华;纪新强;高占军. CEACAM1与CD105在子宫内膜癌中的表达及意义[J]. 实用肿瘤学杂志, 2008, 22(01): 35-37.
[11]	谷小虎;赵宜良. FOLFOX方案行胃癌新辅助化疗38例疗效观察[J]. 实用肿瘤学杂志, 2006, 20(06): 538-540.
[12]	王莉;俞春江;耿敬姝. 缺氧诱导因子-1α、VEGF在进展期胃癌中的表达及意义[J]. 实用肿瘤学杂志, 2005, 19(05): 337-340.
[13]	张晓伟;汪洁;朱华. CLIA方法检测肿瘤患者血清CEA含量临床意义[J]. 实用肿瘤学杂志, 2005, 19(04): 283-284.
[14]	王飞;丑伟平;杨舜. 多瑞吉在癌症患者术后镇痛中的应用与临床观察[J]. 实用肿瘤学杂志, 2005, 19(01): 14-16.
[15]	郝志强;林杰;付庆才. CA19-9和CEA检测在胰头癌诊断的应用分析[J]. 实用肿瘤学杂志, 2004, 18(06): 416-418.

外周血中CEA和CA19-9的表达水平在进展期胃癌中的预后价值

Prognostic value of CEA and CA19-9 expression in peripheral blood of patients with advanced gastric cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价